Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • Magazine: Digital twins become the new battleground for CDMOs
  • Manufacturing

Magazine: Digital twins become the new battleground for CDMOs

Pharmaceutical Technology

In this issue: CDMOs use of digital twins to realise a strategic advantage, Physical AI's rise in pharma manufacturing, and more.

ManufacturingRead full story

pharminent April 20, 2026 (Last updated: April 20, 2026)

Pharmaceutical Technology

In this issue: CDMOs use of digital twins to realise a strategic advantage, Physical AI’s rise in pharma manufacturing, and more.

ManufacturingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: What actually drives speed in complex drug development programs
Next: UCB cuts $1.15bn deal to buy epilepsy biotech Neurona

Related Stories

  • Manufacturing

Lilly and Resilience invest $750M in diabetes and obesity drug device supply

pharminent July 31, 2026
  • Manufacturing

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

pharminent July 29, 2026
  • Manufacturing

GSK to quit Stevenage for new R&D site in Cambridge

pharminent July 28, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.